Intellia Therapeutics | DEFA14A: Others
Apr 29 16:58 ET
Intellia Therapeutics | ARS: Annual Report to Security Holders
Apr 29 16:38 ET
Intellia Therapeutics | DEF 14A: Definitive information statements
Apr 29 16:20 ET
Intellia Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Dube Michael P
Apr 22 16:13 ET
Intellia Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Apr 16 16:18 ET
Intellia Therapeutics | 8-K: Current report
Apr 15 16:26 ET
Intellia Therapeutics | 8-K: Current report
Mar 22 09:27 ET
Intellia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Sepp-Lorenzino Laura
Mar 5 16:17 ET
Intellia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer BASTA JAMES
Mar 5 16:17 ET
Intellia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hicks Derek
Mar 5 16:16 ET
Intellia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Clark Eliana
Mar 5 16:16 ET
Intellia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Goddard Glenn
Mar 5 16:15 ET
Intellia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lebwohl David
Mar 5 16:15 ET
Intellia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LEONARD JOHN M
Mar 5 16:15 ET
Intellia Therapeutics | 424B5: Prospectus
Feb 26 07:05 ET
Intellia Therapeutics | 424B5: Prospectus
Feb 23 22:28 ET
Intellia Therapeutics | 8-K: Current report
Feb 23 17:21 ET
Intellia Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Feb 22 16:20 ET
Intellia Therapeutics | 10-K: Annual report
Feb 22 16:07 ET
Intellia Therapeutics | 8-K: Intellia Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Company Progress
Feb 22 07:46 ET
No Data
No Data